Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials-Reference-Cited by-同舟云学术

Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials

Published:2020-04 Issue:4 Volume:31 Page:525-531
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chalabi M.,Cardona A.,Nagarkar D.R.,Dhawahir Scala A.,Gandara D.R.,Rittmeyer A.,Albert M.L.,Powles T.,Kok M.,Herrera F.G.

Funder

F. Hoffmann-La Roche Ltd

F Hoffmann-La Roche

Genentech

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference24 articles.

1. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012

2. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

3. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma;Ribas;JAMA,2016

4. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014

5. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer;Rizvi;Science,2015

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids;Respiratory Investigation;2024-11

2. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

3. What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?;Journal of Stomatology, Oral and Maxillofacial Surgery;2024-09

4. Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study;Journal of Geriatric Oncology;2024-09

5. Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer;Journal of Cancer Research and Clinical Oncology;2024-08-22